Initial formation of IGROV1 ovarian cancer multicellular aggregates involves vitronectin
- PMID: 20358426
- DOI: 10.1007/s13277-010-0017-9
Initial formation of IGROV1 ovarian cancer multicellular aggregates involves vitronectin
Abstract
Ovarian cancer progression is frequently associated with the development of malignant ascites. Multicellular aggregates of carcinoma cells (spheroids) found within ascites are thought to be able to promote peritoneal carcinomatosis. We have previously demonstrated the involvement of the vitronectin/alphav integrin adhesive system in the dissemination of ovarian cancer cells and continue to investigate the influence of these molecules by studying their role(s) in spheroid behavior. The aim of this study was to generate ovarian cancer multicellular aggregates and to focus on the role of vitronectin and alphav integrins in their initiation. IGROV1 cancer cells cultured in the absence of adhesive substratum formed multicellular aggregates comparable to spheroids. After 21 days, a fraction of the cells within clusters remained viable and proliferated recurrently. Within the multicellular aggregates, vitronectin and alphav integrins were co-localized at intercellular sites, suggesting their involvement in cell-cell interactions. Initial formation of IGROV1 aggregates was inhibited using anti-vitronectin and anti-alphav integrin blocking antibodies or the cyclic peptide cRGDfV. Vitronectin expression persisted during cluster disaggregation on fibronectin. These results demonstrate the ability of IGROV1 cells to generate multicellular aggregates and point to a contributory role for the vitronectin/alphav integrin system in the initial step of this process. These events could represent a prerequisite for further dissemination.
Similar articles
-
Vitronectin and its receptors partly mediate adhesion of ovarian cancer cells to peritoneal mesothelium in vitro.Tumour Biol. 2008;29(4):231-44. doi: 10.1159/000152941. Epub 2008 Sep 9. Tumour Biol. 2008. PMID: 18781095
-
Cell cycle arrest or survival signaling through αv integrins, activation of PKC and ERK1/2 lead to anoikis resistance of ovarian cancer spheroids.Exp Cell Res. 2014 Jan 15;320(2):329-42. doi: 10.1016/j.yexcr.2013.11.011. Epub 2013 Nov 27. Exp Cell Res. 2014. PMID: 24291221
-
Adhesion of human ovarian adenocarcinoma IGROV1 cells to endothelial cells is partly mediated by the alphav integrins-vitronectin adhesive system and induces an alteration of endothelial integrity.Cell Biol Int. 2005 Jun;29(6):482-8. doi: 10.1016/j.cellbi.2005.01.008. Cell Biol Int. 2005. PMID: 15914035
-
Spheroid Formation and Peritoneal Metastasis in Ovarian Cancer: The Role of Stromal and Immune Components.Int J Mol Sci. 2022 Jun 1;23(11):6215. doi: 10.3390/ijms23116215. Int J Mol Sci. 2022. PMID: 35682890 Free PMC article. Review.
-
Multicellular spheroids in ovarian cancer metastases: Biology and pathology.Gynecol Oncol. 2009 Apr;113(1):143-8. doi: 10.1016/j.ygyno.2008.11.032. Epub 2009 Jan 10. Gynecol Oncol. 2009. PMID: 19135710 Review.
Cited by
-
Evaluation of the potential of a new ribavirin analog impairing the dissemination of ovarian cancer cells.PLoS One. 2019 Dec 11;14(12):e0225860. doi: 10.1371/journal.pone.0225860. eCollection 2019. PLoS One. 2019. PMID: 31825993 Free PMC article.
-
PAI-1: An Integrator of Cell Signaling and Migration.Int J Cell Biol. 2011;2011:562481. doi: 10.1155/2011/562481. Epub 2011 Aug 3. Int J Cell Biol. 2011. PMID: 21837240 Free PMC article.
-
Constitutive activation of integrin αvβ3 contributes to anoikis resistance of ovarian cancer cells.Mol Oncol. 2021 Feb;15(2):503-522. doi: 10.1002/1878-0261.12845. Epub 2020 Dec 1. Mol Oncol. 2021. PMID: 33155399 Free PMC article.
-
Hydrogel Microwell Arrays Allow the Assessment of Protease-Associated Enhancement of Cancer Cell Aggregation and Survival.Microarrays (Basel). 2013 Aug 22;2(3):208-27. doi: 10.3390/microarrays2030208. Microarrays (Basel). 2013. PMID: 27605189 Free PMC article.
-
The Transcoelomic Ecosystem and Epithelial Ovarian Cancer Dissemination.Front Endocrinol (Lausanne). 2022 Apr 28;13:886533. doi: 10.3389/fendo.2022.886533. eCollection 2022. Front Endocrinol (Lausanne). 2022. PMID: 35574025 Free PMC article. Review.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical